Bladder Cancer Research: Multiplexed autoantibody profiling | Dana-Farber Cancer Institute
0 Views
administrator
07/08/23
Dana-Farber's Guru Sonpavde, MD, highlights research from ASCO GU22: Multiplexed autoantibody profiling of patients with metastatic urothelial carcinoma receiving immune checkpoint inhibitors or platinum-based chemotherapy. http://ms.spr.ly/6053wztS1
Video published 2/15/22
-
Category
Show more
Facebook Comments
No comments found